BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
20 results:

  • 1. Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive bone Marrow Characterization From Whole-Body MRI: A Multicentric Feasibility Study.
    Wennmann M; Klein A; Bauer F; Chmelik J; Grözinger M; Uhlenbrock C; Lochner J; Nonnenmacher T; Rotkopf LT; Sauer S; Hielscher T; Götz M; Floca RO; Neher P; Bonekamp D; Hillengass J; Kleesiek J; Weinhold N; Weber TF; Goldschmidt H; Delorme S; Maier-Hein K; Schlemmer HP
    Invest Radiol; 2022 Nov; 57(11):752-763. PubMed ID: 35640004
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Utility of an automatic adaptive iterative metal artifact reduction AiMAR algorithm in improving CT imaging of patients with hip prostheses evaluated for suspected bladder malignancy.
    Mohammadinejad P; Khandelwal A; Inoue A; Takahashi H; Yalon M; Long Z; Halaweish AF; Leng S; Yu L; Lee YS; McCollough CH; Fletcher JG
    Abdom Radiol (NY); 2022 Jun; 47(6):2158-2167. PubMed ID: 35320381
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Dosimetric impact of using a commercial metal artifact reduction tool in carbon ion therapy in patients with hip prostheses.
    Zhao J; Wang W; Shahnaz K; Wu X; Mao J; Li P; Zhang Q
    J Appl Clin Med Phys; 2021 Jul; 22(7):224-234. PubMed ID: 34159721
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of ordered-subset expectation maximization and filtered back projection reconstruction based on quantitative outcome from dynamic [18F]NaF PET images.
    Wong JM; Puri T; Siddique MM; Frost ML; Moore AEB; Blake GM; Fogelman I
    Nucl Med Commun; 2021 Jun; 42(6):699-706. PubMed ID: 33625180
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The transcriptional regulator fubp1 influences disease outcome in murine and human myeloid leukemia.
    Hoang VT; Verma D; Godavarthy PS; Llavona P; Steiner M; Gerlach K; Michels BE; Bohnenberger H; Wachter A; Oellerich T; Müller-Kuller U; Weissenberger E; Voutsinas JM; Oehler VG; Farin HF; Zörnig M; Krause DS
    Leukemia; 2019 Jul; 33(7):1700-1712. PubMed ID: 30635626
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Interplay between transcription regulators RUNX1 and fubp1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
    Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
    Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Texture analysis for automated evaluation of Jaszczak phantom SPECT system tests.
    Nichols KJ; DiFilippo FP; Palestro CJ
    Med Phys; 2019 Jan; 46(1):262-272. PubMed ID: 30418674
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma.
    Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI
    Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Fast Megavoltage Computed Tomography: A Rapid Imaging Method for Total Body or Marrow Irradiation in Helical Tomotherapy.
    Magome T; Haga A; Takahashi Y; Nakagawa K; Dusenbery KE; Hui SK
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):688-95. PubMed ID: 27681766
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
    Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
    Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Alternative Splicing Detection as a Biomarker for cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
    Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
    Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Alternative Splicing Detection as Biomarker Candidates for cancer Diagnosis and Treatment with Establishment of Clinical Biobank in Chiba University].
    Matsushita K; Itoga S; Nishimura M; Furuta K; Nomura F
    Rinsho Byori; 2015 Mar; 63(3):347-60. PubMed ID: 26524858
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The proteome profile of the human osteosarcoma U2OS cell line.
    Niforou KM; Anagnostopoulos AK; Vougas K; Kittas C; Gorgoulis VG; Tsangaris GT
    Cancer Genomics Proteomics; 2008; 5(1):63-78. PubMed ID: 18359981
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used.
    Divoli A; Bloch G; Chittenden S; Malaroda A; O'Sullivan JM; Dearnaley DP; Flux GD
    Cancer Biother Radiopharm; 2007 Feb; 22(1):121-4. PubMed ID: 17627420
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Reducing bladder artifacts in clinical pelvic SPECT images.
    Wells RG; Farncombe T; Chang E; Nicholson RL
    J Nucl Med; 2004 Aug; 45(8):1309-14. PubMed ID: 15299054
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
    Etchebehere EC; Macapinlac HA; Gonen M; Humm K; Yeung HW; Akhurst T; Scher HI; Larson SM
    Q J Nucl Med; 2002 Jun; 46(2):122-30. PubMed ID: 12114875
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Streak artifact reduction in filtered backprojection using a level line-based interpolation method.
    Bruyant PP; Sau J; Mallet JJ
    J Nucl Med; 2000 Nov; 41(11):1913-9. PubMed ID: 11079504
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Folliculocentric basaloid proliferation. The bulge (der Wulst) revisited.
    Leshin B; White WL
    Arch Dermatol; 1990 Jul; 126(7):900-6. PubMed ID: 2360837
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.